close
Jump to content

ICON PLC

Add links
From Wikipedia, the free encyclopedia
(Redirected from ICON plc)
ICON plc
TypePublic
Nasdaq: ICLR
Industry
Founded1990; 36 years ago (1990) in Dublin, Ireland
Founders
  • John Climax
  • Ronan Lambe
Headquarters
Dublin
,
Ireland
Key people
  • Barry Balfe (CEO)
  • Nigel Clerkin (CFO)
ProductsServices for pharmaceutical, biotech and medical device industries
RevenueIncrease US$8.28 billion (2024)
Increase US$705.05 million (2024)
Total assetsDecrease US$16.88 billion (2024)
Number of employees
41,900 (2024)
Websitewww.iconplc.com

Icon plc (stylized as "ICON") is an Irish-headquartered multinational clinical research organisation (CRO). Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress.[1]

As of December 2025 Icon had approximately 40,100 employees in 55 countries.[2]

History

[edit]

Icon was founded in Ireland, by John Climax and Ronan Lambe in 1990.[3] Since January 2010, Climax has held a position on the board of directors. Lambe retired from the board of directors in 2018.[4]

Between 1991 and 1996, Icon opened offices in the United Kingdom, United States, Germany, and Japan.[5] Two years later, Icon shares began trading on Nasdaq.[6]

In March 2017, Steve Cutler was appointed chief executive officer of Icon.[7]

On September 4, 2025, Icon announced that Steve Cutler would be stepping down from his position. Barry Balfe, the company's Chief Operating Officer, was promoted to Chief Executive Officer.[8]

Acquisitions

[edit]
  • 2000: Icon acquired UK-based regulatory consultancy, YRCR Ltd.; Central Laboratory in New York; and bioanalytical consultancy, Pacific Research[9][10][11]
  • 2002: Icon acquired clinical research provider, BPA.[12]
  • 2003: Icon acquired Medieval, a UK-based Phase I facility, and US consulting firm, Globomax [13][14]
  • 2004: Icon acquired medical imaging specialist, Beacon Bioscience Inc.[15]
  • 2006: Icon acquired outcomes research and health economics specialist, Ovation Research Group[16]
  • 2007: Icon acquired European staffing group, DOCS International[17]
  • 2008: Icon acquired US phase I provider, Healthcare Discoveries and US bioanalytical lab, Prevalere Life Sciences[18][19]
  • 2009: Icon acquired Veeda Laboratories, a UK biomarker lab[20]
  • 2010: Icon acquired Timaq Medical Imaging Inc.[21]
  • 2011: Icon acquired Oxford Outcomes, an international health outcomes consultancy and Firecrest Clinical, a technology provider specialising in site performance and study management[22][23]
  • 2012: Icon acquired PriceSpective, a global value strategy consultancy and Chinese CRO, BeijingWits[24][25]
  • 2013: Icon acquired staffing and FSP providers, ClinForce and Assent and Akos, an EU provider of pharmacovigilance and drug safety services[26][27]
  • 2014: Icon acquired Aptiv Solutions, a market leader in adaptive trial design and execution[28]
  • 2015: Icon acquired MediMedia Pharma Solutions to enhance market access and scientific communications capabilities, and PMG Research Inc., an integrated network of clinical research sites in the US[29][30]
  • 2016: Icon acquired Clinical Research Management Inc., to extend its presence in the government-sponsored research market[31]
  • 2017: Icon acquired MAPI Group, thereby becoming the world's second-largest provider of late-phase services[32]
  • 2019: Icon acquired Symphony Clinical Research, a leading provider of at-home patient services and site-support services; MediNova, an integrated network of clinical research sites across EMEA; and MolecularMD, to enhance its laboratory offerings in molecular diagnostic testing and immunohistochemistry[33][34][35]
  • 2020: Icon acquired MedPass International, a leading European medical device CRO, regulatory and reimbursement consultancy[36]
  • 2021: Icon acquired PRA Health Sciences, a competitor offering clinical research services, for US$12 billion. Upon completion of the transaction, PRA shareholders will own approximately 34 percent of the shares of the combined company and Icon shareholders will own approximately 66 percent.[37][38]

Finances

[edit]
YearRevenue
(in thousands USD)		Net Income
(in thousands USD)		Total Assets
(in thousands USD)		Employees
(k)
2020[39]2,797,288332,9643,435,60615,730
2021[40]5,480,826153,18517,387,09038,330
2022[41]7,741,386505,30417,185,27841,100
2023[42]8,120,176612,33516,989,86341,100
2024[43]8,281,676705,05116,877,67841,900
2025[44] 8,251,340 230,363 16,088,220 40,100

Recognition

[edit]

In 2018, Icon won PharmaTimes Clinical Researcher of the Year.[45] In 2021, Icon was awarded PharmaTimes Clinical Research Company of the Year,[46] and in 2022, won Best Contract Research Organisation (FSP) [47] at the Scrip Awards.

See also

[edit]

References

[edit]
  1. ↑ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  2. ↑ "Facts and Figures". ICON plc. Retrieved 21 April 2025.
  3. ↑ "Icon founders poised to make $45m in share placing". Irish Times. 24 July 2003. Retrieved 8 December 2019.
  4. ↑ "Board of Directors". Red Robin Gourmet Burgers, Inc. 2023. Retrieved 2023-11-01.
  5. ↑ Langan, Sheila (1 October 2014). "ICON of Ireland". Irish America. Retrieved 8 December 2019.
  6. ↑ "ICON plc : ICON Announces the Commencement of Direct Trading on NASDAQ". Market Screener. 5 February 2013. Retrieved 8 December 2019.
  7. ↑ "BRIEF-ICON says Steve Cutler to be named CEO". Reuters. 20 October 2016. Retrieved 8 December 2019.
  8. ↑ "ICON Announces CEO Transition". Business Wire. Business Wire. 4 September 2025. Retrieved 4 September 2025.
  9. ↑ "YRCR was acquired by Icon on February 3, 2000". Mergr. Retrieved 8 December 2019.
  10. ↑ Barrington, Kathleen (10 June 2000). "Icon buys UCT for $2m cash plus $18m deferred payments". Independent. Retrieved 8 December 2019.
  11. ↑ McGrath, Brendan (1 February 2000). "Icon buys US data group in first public acquisition". The Irish Times. Retrieved 8 December 2019.
  12. ↑ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  13. ↑ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  14. ↑ "ICON Acquires GloboMax". Mergr. Retrieved 8 December 2019.
  15. ↑ "Beacon Bioscience Acquired by ICON July 1, 2004". Crosstree Capital. Retrieved 8 December 2019.
  16. ↑ "ICON Acquires Ovation Research Group". Mergr. Retrieved 8 December 2019.
  17. ↑ Mansell, Peter (16 July 2007). "ICON acquires clinical research staffer DOCS International". Pharma Times. Retrieved 8 December 2019.
  18. ↑ "ICON Acquires Healthcare Discoveries". Contract Pharma. 12 February 2008. Retrieved 8 December 2019.
  19. ↑ MacDonald, Gareth (22 October 2009). "Icon boosts bioanalytical presence through Prevalere buy". Outsourcing Pharma. Retrieved 8 December 2019.
  20. ↑ "ICON Acquires Veeda Laboratories Ltd". Biospace. 8 December 2008. Retrieved 8 December 2019.
  21. ↑ Rhea, Shawn (24 May 2010). "Icon acquires Timaq Medical Imaging". Modern Healthcare. Retrieved 10 December 2019.
  22. ↑ Mansell, Peter (18 January 2011). "ICON broadens late-phase expertise with Oxford Outcomes acquisition". PharmaTimes. Retrieved 10 December 2019.
  23. ↑ Lynch, Suzanne (15 July 2011). "Pharmaceutical firm Icon buys Firecrest Clinical for undisclosed sum". The Irish Times. Retrieved 10 December 2019.
  24. ↑ "ICON-PLC Acquires PriceSpective". Biospace. 28 February 2012. Retrieved 10 December 2019.
  25. ↑ "ICON Acquires BeijingWits Medical Consulting Ltd". BioSpace. 12 December 2011. Retrieved 10 December 2019.
  26. ↑ "DOCS Acquires ClinForce and Assent Consulting". DOCS Global. DOCS. Archived from the original on 11 December 2019. Retrieved 10 December 2019.
  27. ↑ Mansell, Peter (5 February 2013). "Icon to acquire Cross Country's Clinical Trial Services Division". PharmaTimes. Retrieved 10 December 2019.
  28. ↑ Mansell, Peter (1 April 2014). "ICON to acquire Aptiv Solutions for US$143.5 million". PharmaTimes. Retrieved 10 December 2019.
  29. ↑ "ICON Completes Acquisition Of MediMedia Pharma Solutions". BioSpace. 2 March 2015. Retrieved 10 December 2019.
  30. ↑ "ICON Acquires PMG Research". Contract Pharma. 7 December 2015. Retrieved 10 December 2019.
  31. ↑ "ICON Completes the Acquisition of Clinical Research Management, Inc". BusinessWire. 19 September 2016. Retrieved 10 December 2019.
  32. ↑ "ICON Acquires Mapi Group". Health Economics. Archived from the original on 11 December 2019. Retrieved 10 December 2019.
  33. ↑ "Symphony Clinical Research Acquired by ICON". Symphony Clinical Research. Retrieved 10 December 2019.
  34. ↑ "ICON's Acquisition of MeDiNova Research". Bloomberg. 23 May 2019. Retrieved 10 December 2019.
  35. ↑ Pennic, Fred (21 February 2019). "ICON Acquires Precision Medicine for Oncology Company MolecularMD". HIT Consultant. Retrieved 10 December 2019.
  36. ↑ "ICON Acquires MedPass International". Bloomberg. Retrieved 19 February 2020.
  37. ↑ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  38. ↑ Parsons, Lucy (2021-02-26). "ICON to acquire PRA Health Sciences in $12bn deal". PharmaTimes. Retrieved 2021-10-19.
  39. ↑ "ICON plc Annual Form 20-F Report 2020". U.S. Securities and Exchange Commission. 24 February 2021. Retrieved 21 April 2025.
  40. ↑ "ICON plc Annual Form 20-F Report 2021". U.S. Securities and Exchange Commission. 1 March 2022. Retrieved 21 April 2025.
  41. ↑ "ICON plc Annual Form 20-F Report 2022". U.S. Securities and Exchange Commission. 24 February 2023. Retrieved 21 April 2025.
  42. ↑ "ICON plc Annual Form 20-F Report 2023". U.S. Securities and Exchange Commission. 23 February 2024. Retrieved 21 April 2025.
  43. ↑ "ICON plc Annual Form 20-F Report 2024". U.S. Securities and Exchange Commission. 21 February 2025. Retrieved 21 April 2025.
  44. ↑ "XBRL Viewer". www.sec.gov. Retrieved 2026-07-10.
  45. ↑ "Winner 2018". Pharma Times. December 2018. Archived from the original on 11 December 2019. Retrieved 8 December 2019.
  46. ↑ "Clinical Researcher of the Year - The Americas 2021 winners announced". Pharma Times. October 2021. Retrieved 29 October 2021.
  47. ↑ "Scrip Awards 2022 Winners have been Announced". Pharma Intelligence UK Limited. November 2022. Retrieved 30 November 2022.
[edit]
  • Official website
  • Business data for ICON PLC:
Retrieved from "https://en.wikipedia.org/w/index.php?title=ICON_PLC&oldid=1363558552"